These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27873621)

  • 1. Treatment of extensively drug-resistant Gram-negative infections in critically ill patients: Outcome of a consensus meeting at the 13th Asia-Pacific Congress of Clinical Microbiology and Infection, October 2012.
    Tambyah PA; Hara GL; Daikos GL; Falagas ME; Mazzei T; Mouton JW; Novelli A; Chen B; Wang M; Ko WC; Li T; Fan X; Theuretzbacher U
    J Glob Antimicrob Resist; 2013 Sep; 1(3):117-122. PubMed ID: 27873621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory diagnosis, clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement.
    ; Guan X; He L; Hu B; Hu J; Huang X; Lai G; Li Y; Liu Y; Ni Y; Qiu H; Shao Z; Shi Y; Wang M; Wang R; Wu D; Xie C; Xu Y; Yang F; Yu K; Yu Y; Zhang J; Zhuo C
    Clin Microbiol Infect; 2016 Mar; 22 Suppl 1():S15-25. PubMed ID: 26627340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous colistin for multidrug-resistant gram-negative infections in critically ill pediatric patients.
    Kapoor K; Jajoo M; Dublish S; Dabas V; Gupta S; Manchanda V
    Pediatr Crit Care Med; 2013 Jul; 14(6):e268-72. PubMed ID: 23689704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infections Caused by Resistant Gram-Negative Bacteria: Epidemiology and Management.
    Kaye KS; Pogue JM
    Pharmacotherapy; 2015 Oct; 35(10):949-62. PubMed ID: 26497481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region.
    Hsueh PR; Hoban DJ; Carmeli Y; Chen SY; Desikan S; Alejandria M; Ko WC; Binh TQ
    J Infect; 2011 Aug; 63(2):114-23. PubMed ID: 21669223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens.
    Poulakou G; Bassetti M; Righi E; Dimopoulos G
    Future Microbiol; 2014; 9(9):1053-69. PubMed ID: 25340835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial susceptibility among gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial.
    Bertrand X; Dowzicky MJ
    Clin Ther; 2012 Jan; 34(1):124-37. PubMed ID: 22154196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in multidrug-resistant gram-negative bacilli and the role of prolonged β-lactam infusion in the intensive care unit.
    Guervil DJ; Chau T
    Crit Care Nurs Q; 2013; 36(4):345-55. PubMed ID: 24002425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on the management of urinary tract infections in the era of antimicrobial resistance.
    Bader MS; Loeb M; Brooks AA
    Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of tigecycline and other antimicrobials against Gram-negative and Gram-positive organisms collected from the Asia-Pacific Rim as part of the Tigecycline Evaluation and Surveillance Trial (TEST).
    Bouchillon SK; Iredell JR; Barkham T; Lee K; Dowzicky MJ
    Int J Antimicrob Agents; 2009 Feb; 33(2):130-6. PubMed ID: 18995992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
    Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
    Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of extensively drug-resistant gram negative bacilli in surgical intensive care in Egypt.
    Hasanin A; Eladawy A; Mohamed H; Salah Y; Lotfy A; Mostafa H; Ghaith D; Mukhtar A
    Pan Afr Med J; 2014; 19():177. PubMed ID: 25815098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study.
    Kiratisin P; Chongthaleong A; Tan TY; Lagamayo E; Roberts S; Garcia J; Davies T
    Int J Antimicrob Agents; 2012 Apr; 39(4):311-6. PubMed ID: 22386743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
    Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
    Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistant gram-negative infections. Bringing back the old.
    Chan-Tompkins NH
    Crit Care Nurs Q; 2011; 34(2):87-100. PubMed ID: 21407003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe.
    Souli M; Galani I; Giamarellou H
    Euro Surveill; 2008 Nov; 13(47):. PubMed ID: 19021957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial.
    Giammanco A; Calà C; Fasciana T; Dowzicky MJ
    mSphere; 2017; 2(1):. PubMed ID: 28124025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug-Resistant Gram-Negative Bacilli: Infection Control Implications.
    Adler A; Friedman ND; Marchaim D
    Infect Dis Clin North Am; 2016 Dec; 30(4):967-997. PubMed ID: 27660090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with intravenous colistin for management of infections due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis.
    Kasiakou SK; Michalopoulos A; Soteriades ES; Samonis G; Sermaides GJ; Falagas ME
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3136-46. PubMed ID: 16048915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients.
    Markou N; Apostolakos H; Koumoudiou C; Athanasiou M; Koutsoukou A; Alamanos I; Gregorakos L
    Crit Care; 2003 Oct; 7(5):R78-83. PubMed ID: 12974973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.